Abstract
Sedentary lifestyle is associated with increased incidence of diabetes mellitus, whereas exercise training improves metabolic control and therefore may contribute to prevention of various chronic complications. Diabetic kidney disease is the most common microvascular complication of diabetes mellitus, and is associated with increased mortality from cardiovascular disease in diabetic patients. The literature highlights oxidative stress, renal inflammation, and activation of the renin-angiotensin-aldosterone system as the main pathophysiological mechanisms underlying tissue damage, extracellular matrix accumulation, and renal function deficit. Unfortunately, although the benefits of exercise training on cardiovascular diseases are well established, their impact on the pathophysiological mechanisms involved in the development and progression of diabetic kidney disease is not well understood. In addition, standardization of experimental models and physical rehabilitation programs in diabetic kidney disease are scarce. In this article, we present a brief review of the pathogenesis and pathophysiological mechanisms of diabetic kidney disease,and bring to light the latest findings in the literature on the impact of exercise training on diabetic kidney disease progression.
Impact statement
Diabetic kidney disease (DKD) is associated with increased mortality in diabetic patients and has a negative impact on public health. The identification of potential therapies that help the management of DKD can contribute to the improvement of health and quality of life of patients. Thus, this paper is timely and relevant because, in addition to presenting a concise review of the pathogenesis and major pathophysiological mechanisms of DKD, it addresses the most recent findings on the impact of exercise training on this disease. Thus, since non-pharmacological interventions have gained increasing attention in the fight against chronic diseases, this paper appears as an important tool to increase knowledge and stimulate innovative research on the impact of exercise on kidney disease.
Keywords: Diabetes mellitus, exercise training, diabetic kidney disease
Introduction
Sedentary behavior is associated with metabolic disruption, contributing to the increased incidence of diabetes mellitus (DM). According to the International Diabetes Federation, about 463 million people worldwide have DM, and this number may rise to 700,2 million in 2045.1 On the other hand, regular physical activity is an important element of the therapeutic plan of diabetic patients, effectively contributing to metabolic control and the prevention of chronic complications.2 However, the role of exercise in diabetic kidney management is not well established.
Diabetic kidney disease (DKD) is the most common microvascular complication of DM, associated with increased mortality due to cardiovascular disease in diabetic patients,3 and considered as one of the main causes of end-stage renal disease (ESRD).4 The main modifiable risk factors associated with the development of DKD include hyperglycemia, hypertension, dyslipidemia, and smoking.5 Because of its high morbimortality and large socioeconomic costs, it is urgent to identify effective therapeutic strategies against the DKD progression in order to improve the prognosis of these patients.
Experimental studies have shown that early stages of DKD are characterized by glomerular hyperfiltration, adaptive renal hypertrophy, and microalbuminuria, which may be attributed to DM-induced hemodynamic and metabolic disorders.6–8 The perpetuation of these conditions leads to dense proteinuria, loss of nephron, and progressive fall in glomerular filtration rate (GFR).9,10 Hyperfiltration is an initial common stage observed in patients with type 1 diabetes mellitus (T1DM), which predisposes to the development of micro or macroalbuminuria.11 However, renal hyperfiltration in some diabetic patients was not a risk factor for the development of microalbuminuria.12 In addition to mesangial expansion and diffuse thickening of the glomerular basement membrane, histological changes in the tubulointerstitial compartment are also consistent feature of DKD. Tubulointerstitial lesions in DKD are characterized by interstitial inflammation, thickening of the tubular basement membrane, tubular atrophy, and interstitial fibrosis.13
The pathophysiological mechanisms by which DM causes kidney injury are complex and not fully understood. However, it is well established that the involvement of metabolic and hemodynamic disorders typical of DM converges to extracellular matrix (ECM) accumulation, oxidative stress, renal inflammation, and activation of renin-angiotensin-aldosterone system (RAAS), which are determinant for the onset and progression of tissue lesions.14–16
Currently, despite the renoprotective actions of pharmacological therapies available targeting glycemic and blood pressure controls, the incidence of DKD continues to increase.1 Therefore, new strategies are necessary to prevent or mitigate the progression of DKD and its effects on target organs. Thus, in the last decade, some studies have shown that regular physical activity can improve tissue function and slow the progression of DKD in both experimental animals and humans. In this sense, moderate exercise training, besides benefiting metabolic control, improves the kidney function, reduces microalbuminuria, restores oxidative balance, and increases nitric oxide (NO) bioavailability in streptozotocin (STZ)-induced diabetic rats6,17 and diabetic patients.18 Studies with experimental animals from our laboratory reported that moderate-intensity exercise training, especially when initiated before DM induction, improved metabolic control and attenuated the renal function and structure changes in STZ-induced diabetic female rats.7 Also, our most recent studies suggest that a reduction of oxidative stress and inflammation induced by exercise can contribute to this process.8,19
In the present paper, we have briefly reviewed the main pathophysiological mechanisms of DKD and presented the latest findings on the impacts of aerobic exercise on the progression of DKD.
Methods
We searched the PubMed database for English-language articles, and non-English articles were excluded. The initial screening of literature was based on title and abstract, using keywords such as diabetes mellitus; diabetic kidney/renal disease; diabetic nephropathy; physical exercise and exercise training. Targeted searches were conducted using terms such as pathophysiology of diabetic kidney disease, pathogenesis of diabetic kidney disease, and physical exercise in diabetic kidney disease. We made no restrictions on the publication dates of articles.
Pathophysiology and pathogenesis of diabetic kidney disease
DKD is characterized by several morphological changes that involve all sections of the kidney, culminating in renal dysfunctions. Glomerulosclerosis is one of the major histological changes in DKD. However, histological changes in the tubulointerstitial compartment play a key role in the pathogenesis and progression of this disease.20
Early renal changes of DKD include glomerular hyperfiltration, thickening of the basement membrane, ECM expansion, and adaptive renal hypertrophy.7,9,21 However, often the disease can progress with loss of filtration barrier selectivity and reduction of the filtering surface, resulting in high proteinuria and progressive fall in GFR.9,10 Although hyperfiltration in diabetic patients is also associated with the development of microalbuminuria, some studies have shown that renal hyperfiltration is not a risk factor for the development of microalbuminuria in T1DM.10,12 Histological changes in the tubulointerstitial compartment, mainly involving the proximal tubule, are also related to disease progression, activating several signaling pathways that culminate in tubulointerstitial inflammation and fibrosis, which result in impaired renal function.20
The mechanisms involved in renal injury induced by DM are complex and not fully understood. However, it is evident that hemodynamic and metabolic disorders interact to promote the accumulation of ECM, oxidative stress, and inflammation, which ultimately are responsible for the classic changes that characterize the DKD, as summarized in Figure 1.
Figure 1.
Overview of the pathophysiological mechanisms of diabetic kidney disease. Metabolic changes are related to AGEs formation and activation of the polyol and PKC pathways. These pathways result in the generation of ROS and consequent reduction of NO levels. The NO when reduced exacerbates TGF-β1 bioactivity. ROS and PKC activate NF-кB, which, in turn, increases the expression of TGF-β1 and CCL2. The CCL2 mediates macrophage infiltration, while TGF-β1 increases fibronectin and other ECM proteins (type I, III, IV collagens) deposition. Infiltrated macrophages express pro-inflammatory cytokines such as IL-1, IL-6, IL-18, TNF-α and increase the expression of adhesion molecules that are responsible for facilitating the macrophages infiltration in the diabetic kidney. The TNF-α is also responsible for activating NF-кB. On the other hand, hemodynamic changes are related to AII expression from mesangial cells and shear stress, leading to proteinuria, which directly causes NF-кB activation. Glomerular hypertension and consequent shear stress stimulate local production of AII, which increase NF-кB activation and consequently inflammation. Abbreviations: AGE: advanced glycation end-product; PKC: protein kinase C; NO: nitric oxide; TGF-β1: transforming growth factor-beta 1; ROS: reactive oxygen species; CCL2: C-C motif chemokine ligand 2; ECM: extracellular matrix; IL: interleukin; TNF-α: tumor necrosis factor alpha; NF-кB: nuclear factor-kappa B; AII: angiotensin II. (A color version of this figure is available in the online journal.)
Hemodynamic disorders
The renal hemodynamics disorders leading to glomerular hyperfiltration in early stages of DKD can be explained mainly by adaptation of tubular function to hyperglycemic state and imbalance between vasodilator and vasoconstrictor factors. In the distal tubule, reduced sodium concentration in response to increased filtered glucose load and sodium and fluid tubular reabsorption22 activates tubuloglomerular feedback, resulting in afferent arteriolar vasodilation, increased intraglomerular pressure and hyperfiltration.22–24 In fact, it has been shown that the expression of sodium-glucose cotransport (SGLT) 2 in the proximal tubules is upregulated in DM, leading to increased proximal reabsorption of sodium.25 Furthermore, recently it was demonstrated that in response to acute hyperglycemia, the SGLT1-nitric oxide synthase (NOS)1-tubuloglomerular feedback pathway mediates the glomerular hyperfiltration.26 Although the tubular reabsorption hypothesis is the major mechanism to explain the glomerular hyperfiltration in early DM, other factors associated with hyperglycemia, such as inflammation and oxidative stress, are associated with increase in nitric oxide27 and angiotensin II (AII) renal production,28 which can alter renal vascular tone, leading to increased hydraulic pressure in the glomerular capillaries and consequent hyperfiltration. Together, these phenomena result in increased GFR, compensatory glomerular hypertrophy, and protein passage through the filtration barrier.
On the other hand, the mechanical stress resulting from these hemodynamic changes chronically, besides promoting endothelial shear stress, also stimulates the production of AII and transforming growth factor beta 1 (TGF-β1), which are key molecules for the induction of ECM accumulation and podocyte injury.9,29 Increased urinary TGF-β1 excretion was associated which proteinuria in patients with diabetic nephropathy.30 Evidence suggests that increased expression of ECM proteins in the diabetic kidney is mainly mediated by profibrogenic cytokine TGF-β1. The progressive accumulation of ECM is a critical factor in the progression of DKD, present in both humans31,32 and experimental animals,7,8 and contributes to the development of glomerulosclerosis and tubulointerstitial fibrosis.33,34 Under normal conditions, the main mesangial ECM proteins are fibronectin, laminin, type IV collagen (α1 and α2 chains), and proteoglycans.35,36 However, T1DM metabolic and hemodynamic perturbations activate pathways that lead to imbalance between ECM glycoproteins’ synthesis and their degradation, resulting in abnormal protein accumulation, mainly fibronectin, which constitutes a scaffold for the deposition of other proteins, including collagen IV (α3 and α4 chains) and proteins not normally present in healthy glomeruli, such as type I, III, V, and VI collagens.35,36 High urinary excretion of type IV collagen was related with an annual decline of renal function without overt proteinuria37 and this relationship may be associated with the degree of glomerular and tubulointerstitial impairment in diabetic patients.38 Studies from our laboratory have shown that the accumulation of fibronectin and IV collagen was positively correlated with increased TGF-β1 in the kidneys of STZ-induced diabetic female rats.7 In addition, TGF-β1 stimulated the renal production of type I and III collagens, fibronectin and elastin, and reciprocal inhibition of matrix metalloproteinases and activation of protease inhibitors in STZ-induced diabetic rats.39
Metabolic disorders
Accumulation of advanced glycated end-products
Advanced glycated end-products (AGEs) are formed from non-enzymatic glycosylation of proteins, nucleic acids, and lipids after prolonged exposure to the hyperglycemic environment.40 In the diabetic kidney, AGEs can make stable bonds with long-lived proteins, such as collagen, leading to glomerular basement membrane thickening and inducing greater synthesis of ECM by mesangial cells.41 Besides, AGEs have been associated with reduced NO vasodilatory and antiproliferative responses.42 AGEs can also bind to their receptors (RAGE) present in macrophages, podocytes, and mesangial cells, increasing the production of reactive oxygen species (ROS), which activates nuclear factor kappa B (NF-κB). NF-κB, in turn, induces synthesis of inflammatory and profibrotic cytokines and growth factors, such as tumor necrosis factor alpha (TNF-α), TGFβ-1, and vascular endothelial growth factor (VEGF).43 Thus, the accumulation of AGEs may culminate in increased ECM, mesangial expansion, tissue injury, and progressive renal function deficit.
Activation of polyol pathway
Chronic hyperglycemia may activate the polyol pathway at supraphysiological levels. The hyperglycemic state and the ROS accumulation activate aldose reductase and sorbitol dehydrogenase, which reduce glucose to sorbitol and sorbital to fructose, respectively.44 In this pathway, the greater conversion of glucose to sorbitol using nicotinamide adenine dinucleotide phosphate (NADPH) as a co-factor generates oxidation of NADPH to NADP+, and reduction of oxidized glutathione to reduced glutathione.45 NADPH is required for regenerating reduced glutathione. Therefore, the consumption of NADPH by aldose reductase may lead to decreased antioxidant capacity and oxidative stress. On the other hand, the oxidation of sorbitol to fructose using nicotinamide adenine dinucleotide (NAD+) as a co-factor generates accumulation of NADH.45 The accumulation of polyol pathway products, with consequent increase in NADH/NAD+ ratio, stimulates the synthesis of diacylglycerol, which is the main physiological activator of protein kinase C (PKC).46
Activation of protein kinase C pathways
Chronic hyperglycemia may activate the PKC pathways, which contributes to the pathophysiological process of DKD by increasing oxidative stress and activating pro-sclerotic and pro-inflammatory factors, further increasing tissue damage.47 Activation of PKC pathways contributes to increased ECM accumulation by inducing expression of TGF-β1, fibronectin and type I, III, and IV collagens in streptozotocin-induced diabetic mice.48 On the other hand, increased expression of endothelin-1 (ET-1), VEGF, TGF-β, connective tissue growth factor (CTGF), and type IV and VI collagens induced by diabetes in mice were attenuated by the inhibition of PKC.49 Finally, activation of PKC is capable of activating NF-κB and NAD(P)H oxidase, increasing the expression of multiple pro-inflammatory genes and ROS production, respectively.45
Renal inflammation
The inflammatory process participates in the pathophysiology of DKD, and may, at least in part, explain how metabolic and hemodynamic changes of DM converge to development of tissue lesions. Such inflammatory state is mainly characterized by increased pro-inflammatory cytokines, chemokines, adhesion molecules, transcription factors, and immune cells infiltration.50 However, these features in DKD are considered mild when compared to classic inflammatory diseases, and are therefore termed “microinflammation”.51,52
The increase in ROS induced by hyperglycemia activates the NF-κB, which stimulates adhesion molecules and expression of proinflammatory genes, including monocyte chemoattractant protein-1 (MCP-1), TNF-α, and interleukin (IL)-6.53–56 Studies have shown that renal injury was associated with increased expression of NF-кB in STZ-induced diabetic rats.8,19,57 Activation of NF-кB in renal cells results in increased chemokine CCL2, also known as MCP-1, which is related to macrophage migration to the site of inflammation into kidney tissue.50,51 This chemokine has also its production increased from renal tubulointerstitial lesions and hyperglycemic environments in response to oxidative stress and the presence of AII.51
In addition to attracting macrophages, Tarabra et al.58 demonstrated that increased CCL2 was able to induce downregulation of nephrin, altering podocyte selectivity and contributing to increased proteinuria in streptozotocin-treated mice and human cultured podocytes. On the other hand, macrophages infiltration is correlated with decreased GFR and histological changes in diabetic kidney.51,59 These macrophages are classified into M1 and M2. M1 macrophages are responsible for pro-inflammatory pathways, while M2 macrophages induce remodeling and resolution of inflammation.59,60
Adhesion molecules are critical for the migration of immune cells to injured tissue. The main intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) are expressed on the cell surface and their expression is increased by IL-1 and IL-18, respectively.52 The production of ICAM-1 can be increased by proinflammatory cytokines, shear stress, oxidative stress, activation of PKC and AGEs.51 Also, adhesion molecules are related to selectin expression and consequently induces leukocyte migration into the field of inflammation.50,51,59 According to Okada et al.61 and Lim et al.,62 ICAM-1 is elevated in endothelial cells at hyperglycemic milieu and the exclusion of the ICAM-1 gene improved renal inflammation in mice.
Inflammatory cytokines are involved in pathogenesis of DKD.50,63 IL-1 correlates with prostaglandin E2 production, which has a direct influence on hemodynamics and production of adhesion molecules ICAM-1, VCAM-1, and Selectins E.51 IL-18 is responsible for the increase of interferon-gamma (IFN-γ), which is related to the induction of TNF-α, TGF-β, and VCAM-1.52 IL-6 promotes mesangial cells proliferation and increases fibronectin expression and endothelial cell permeability.54 This cytokine may affect the dynamics of extracellular matrix at mesangial cell and podocytes, promoting to mesangial expansion and glomerular basement membrane thickening.56 TNF-α is expressed by glomerular and proximal tubule cells. It is related to increased inflammation, endothelial permeability, and cytotoxic pathways.51 TNF-α induces a variety of biological effects on renal cells including activation of second messengers, transcription factors, synthesis of cytokines, growth factors, and cell adhesion molecules.64 Macrophages are also responsible for the expression of these cytokines and other pro-inflammatory factors, which contribute to the progression of renal injury.65,66
Renin-angiotensin-aldosterone system
The RAAS plays a key role in regulating water, sodium, and blood pressure. However, RAAS is activated by the hyperglycemic state and mechanical stress that raises AII levels in DKD.66 The glomerulus is affected by AII through vasoconstrictor action on efferent arteriole, leading to increased intraglomerular pressure.52,66 Besides, it also alters the permeability of the glomerular basement membrane and results in the worsening of proteinuria.63 Proteinuria, in turn, is related to increased glomerular expression of NF-кB, which induces TGF-β, MCP-1, ICAM-1, and AGEs accumulation.52 Thus, proteinuria stimulates the activation of inflammatory pathways and oxidative stress, and contributes to the progression of renal lesions.50,66
Importantly, AII is considered a promoter of inflammation and fibrosis by activating NF-кB, MCP-1, TGF-β1, and other proinflammatory cytokines.66 In addition, AII also culminates in elevated aldosterone levels, that besides to playing a key role in water and sodium retention, may cause toxicity and fibrosis in blood vessels, contributing to the deposition of fibronectin, type I, III, and IV collagens, leading to severe interstitial tubular fibrosis.63,66
Type of exercises training recommended for patients with diabetes mellitus
Regular exercise training provides well-being and quality of life, being widely recommended to reduce the risk of cardiovascular problems and cancer in the general population.67,68 Specifically, regular exercise is an important non-pharmacological method to prevent and treat various metabolic disorders and its complications, including both type 1 (T1DM) and type 2 (T2DM) DM. Although the benefits of exercise in individuals with T2DM are better documented,69,70 physical activity also promotes beneficial effects in individuals with T1DM in the absence of contraindications and accompanied with all the necessary support for the optimal management of DM.68,71
In the over past few decades, a crescent number of studies have been trying to understand the benefits of exercise in various pathological conditions,72–75 including the renal disease.76 Usually, physical rehabilitation programs for different human diseases are developed based on the patient’s condition, and mainly include the type, frequency, intensity, and duration of exercise.77,78 Thus, the main types of exercise frequently recommended for patients with DM include aerobic, resistance, combined, and flexibility exercises.68
The aerobic exercise involves repeated and continuous movements of large groups of muscles and induces important health benefits including increased insulin sensitivity, mitochondrial density, oxidative enzymes, lung function, immune function, and cardiac output.67,68 The resistance exercise is characterized by moderate or high intensity physical activity that involves all major muscle groups and activities that use free weights exercise, machines, elastic resistance bands, and even body weight.78 The benefits of resistance exercise are associated with improved cardiovascular, body mass, physical function, insulin sensitivity, blood pressure, and lipid profile.78 The association of aerobic and resistance exercises, named combined exercise, is also recommended to optimize health and general cardiovascular benefits, reducing risk factors related to physical inactivity.79 Other types of physical exercise, such as flexibility, also benefit individuals by stretching the muscles and increasing postural stability and balance, improving movement for other exercises and everyday activities.67 Table 1 provides additional information regarding the intensity, duration, and frequency of each of these types of exercise recommended in DM.
Table 1.
Exercise training recommendations for patients with diabetes mellitus.
| Type of exercise | Intensity | Duration | Frequency |
|---|---|---|---|
| Aerobic | Moderate to vigorous | At least 150 min/week at moderate to vigorous. For adults able to run steadily at 9.7 km/h for 25 min, 75 min/week | 3–7 days/week, with no more than 2 consecutive days without exercise |
| Resistance | Moderate (15 repetitions) to vigorous (6–8 repetitions) | At least 8–10 exercises with completion of 1–3 sets of 10–15 repetitions to near fatigue per set | A minimum of 2, but preferably 3 nonconsecutive days/week |
| Flexibility | Stretch to the point of slight discomfort | Hold static or do dynamic stretch for 10–30 s; 2–4 repetitions of each exercise | A minimum 3 days/week |
Note: Table adapted.68
There are several possible ways to assess exercise intensity in order to better prescribe an exercise protocol.80 With regard to aerobic exercise, the most used methods to estimate the relative intensity of exercise is the heart rate reserve (%HRR) or oxygen uptake reserve (%VO2R), maximum heart rate (%HRmax), maximum oxygen uptake (%VO2max), and rating of perceived exertion (RPE). Regarding the resistance exercise, the main parameter used to determine the intensity is one-repetition maximum (%1-RM). Table 2 shows the classification of exercise intensity commonly used in practice using these parameters.
Table 2.
Classification of the relative intensity of aerobic and resistance exercises.
|
Aerobic |
Resistance exercise |
||||
|---|---|---|---|---|---|
| Intensity | %HRR or VO2R | %HRmax | %VO2max | RPE | %1-RM |
| Low | 30–39 | 57–63 | 37–45 | 9–11 | 30–49 |
| Moderate | 40–59 | 64–76 | 46–63 | 12–13 | 50–69 |
| High | 60–89 | 64–90 | 77–95 | 14–17 | 70–84 |
Note: Table adapted.67
HRR: heart rate reserve; VO2R: oxygen uptake reserve; HRmax: maximum heart rate; RPE: rating of perceived exertion; VO2max: maximum oxygen uptake; 1-RM: one-repetition maximum.
Table 3.
Benefits of physical training on health parameters in diabetic patients.
| Type of exercise | Type 1 diabetes | Type 2 diabetes |
|---|---|---|
| Aerobic | • Improves lipid profile• Reduces insulin resistance• Preserves endothelial function• Reduces cardiovascular mortality | • Improves insulin sensitivity and glucose uptake• Improves lipid profile• Improves pancreatic beta cell function• Reduces renal injury and microalbuminuria• Preserves renal function• Reduces inflammation and oxidative stress• Improves blood pressure control• Preserves endothelial function and reduces cardiovascular mortality |
| Resistance | • Lower risk of hypoglycemia and changes in blood glucose levels compared to aerobic exercise | • Improves glycemic control• Reduces glycated hemoglobin• Improves lean body mass• Improves lipid profile |
| Combined | • No available evidence | • Improves insulin sensitivity• Reduces fasting insulin and glucose• Reduces glycated hemoglobin• Reduces abdominal subcutaneous and visceral adipose tissue• Increases muscle density• Reduces microalbuminuria• Improves blood pressure control |
Effects of low to moderate aerobic exercise training
Regarding the type of exercise, the table 3 shows the benefits of aerobic exercise training as well as resistance and combined exercise on health parameters in diabetic patient. Aerobic training is considered one of the most effective forms of physical activity in promoting benefits against hyperglycemia-induced complications.81 Studies have shown that low to moderate intensity aerobic exercise seems to exert renoprotective effects in patients with T1DM and T2DM18,82–84 and in experimental models of DM.7,8,85,86 Moderate aerobic exercise improved the insulin sensitivity, glucose uptake83,87–89 lipid levels, endothelial function, pancreatic beta cell function, and decreased insulin resistance70,90, tubular injury, and microalbuminuria in patients with T2DM.18 Additionally, a recent study has shown that a calorie-restricted diet associated with this type of exercise reduced inflammation and oxidative stress delayed the development of renal failure by postponing renal fibrosis in patients with T2DM in stage 3 DKD.90 In patients with T1DM, although some studies have shown that exercise has not improved glycemic control,91,92 physical activity improves lipid levels, endothelial function, insulin resistance, and reduces cardiovascular mortality, suggesting that moderate aerobic exercise can be also recommended for these patients, including those with chronic kidney disease (CKD).70,84
Experimental studies have also shown beneficial effects of exercise on metabolic control as well as on DKD progression. In this sense, aerobic exercise of moderate intensity performed for 12 weeks reduced hyperglycemia, glycated hemoglobin, and systolic and mean blood pressure in obese diabetic rats.93 In addition, recent studies from our laboratory showed that moderate aerobic exercise, especially when started before induction of DM, improved the metabolic control, preserved the renal structure and function, and reduced proteinuria and local expression of collagen IV and TGF-β1 in type 1 diabetic female rats.7 We have also demonstrated that this exercise reduced serum creatinine levels, glycosuria, glomerular and tubulointerstitial changes, proteinuria, and lipid peroxidation in ovariectomized diabetic rats.8,94
Effects of high aerobic exercise training
The literature presents controversial results about the impact of high-intensity exercise on glucose homeostasis and progression of kidney disease in diabetic individuals. Such controversy may be due to the different methodologies used in the training protocols, types of DM and stage of DKD.95,96 High-intensity exercise training seems to be a more critical situation for T1DM because these individuals are often more intolerant to exercise and may occur undesirable effects on blood glucose concentrations.97 In this sense, this type of training increases hepatic glucose production and consequently its levels in the bloodstream,98,99 which contributes to worsening of DM and its complications, increasing the risk of premature death in these patients. Additionally, clinical100,101 and experimental studies102 have shown that high-intensity exercise led to the occurrence of post-exercise hypoperfusion and proteinuria in different types of renal disease due to arteriolar vasoconstrictor action induced by elevated catecholamine plasma levels, increased renal sympathetic nerve activity, and subsequent formation of AII.103,104
On the other hand, patients with T1DM who practiced high-intensity exercise showed lower risk of progression to microalbuminuria than patients who perform low and moderate intensity exercise.84 This type of exercise was also associated with a lower incidence and progression of kidney disease, as well as a lower risk of cardiovascular events and mortality in patients with DKD.71,84 Nylen et al.88 demonstrated that a combined training program of moderate to high intensity (50–80% of HRR) for 12 weeks, in addition to improving the cardiometabolic profile of diabetic patients (T2DM) with mild renal dysfunction (stage 2 and 3), was able to improve the post-exercise estimated GFR by up to 12%.88 In that study, the authors also demonstrated that 42% of patients with stage 3 DKD improved to stage 2 after the intervention. Besides, high-intensity exercise prevented the albuminuria and glomerulosclerosis in an experimental model of T2DM.105
Effects of resistance exercise training
Beneficial effects of resistance exercise have been shown in patients on dialysis, improving the creatinine plasma levels106 and inflammation markers.107 Besides, the resistance exercise can also promote benefits to diabetic individuals. In this sense, this type of exercise reduced glycated hemoglobin108 and improved lean body mass, total cholesterol, low density lipoprotein (LDL)-cholesterol, and triglycerides in T2DM individuals.108,109 In women with T2DM, the resistance exercise also reduced the concentration of glucose, suggesting that this type of exercise may be an alternative to improve glycemic control in diabetic patients.110 With regard to the T1DM, the resistance exercise has been less documented. However, this type of exercise was able to induce more stable glucose levels during and after exercise compared to aerobic exercise, inducing less hypoglycemia in these individuals.111 In agreement with these findings, the resistance exercise also attenuated the risk of exercise-induced hypoglycemia in rats with T1DM.112
Effects of combined exercise training
Studies have demonstrated the beneficial effects of combined resistance and aerobic training for glycemic control in diabetic individuals, especially T2DM.79,113 The combined exercise improved insulin sensitivity and this effect was associated with the loss of abdominal, subcutaneous and visceral adipose tissue and increased muscle density in postmenopausal women with T2DM.114 Sigal et al.115 demonstrated that aerobic or resistance exercises alone improved the glycated hemoglobin in patients with T2DM. However, glycemic control was greater in patients with T2DM that performed the combined exercise. Thus, Japanese adults submitted to a combined exercise training program improved the fasting insulin and glucose, glycated hemoglobin, and systolic blood pressure and present decreased urinary albumin:creatinine ratio levels.116
Pathophysiological mechanisms underlying renoprotective action of exercise training on diabetic kidney disease
The mechanisms by which exercise improves kidney structure and function in individuals with DKD are not fully understood, partly due to the scarcity of clinical studies exploring the effects of different exercise training protocols on pathophysiological pathways involved in disease progression. However, experimental studies have been very useful in this regard, supporting the hypothesis that exercise training provides attenuation of metabolic and hemodynamic changes induced by DM, which converge to reductions of oxidative stress, inflammation, and ECM accumulation in the diabetic kidney, as summarized in Figure 2.
Figure 2.
Overview of the exercise training mechanisms attenuating the metabolic and hemodynamic changes of diabetic kidney disease. Exercise promotes metabolic and hemodynamic improvements. Activation of the SIRT1-PGC pathway results in improved mitochondrial function and consequent reduction in muscle catabolism. Glucose uptake is increased by exercise by activating AMPK and insulin-mediated pathways to reduce hyperglycemia, formation of AGEs, and consequently reduction of ROS. Activation of the P2X7 receptor reduces lipid peroxidation and thus attenuates the formation of ROS. Activation of Nfr2 increases the expression of antioxidant enzymes and thus reduces the formation of ROS. Increased cardiac output and renal vasoconstriction provide shear stress, which induces NO production. Elevated NO levels are related to TGF-β1, ECM protein deposition, and fibrosis reductions. Exercise provides angiogenesis and endothelial function by NO, VEGF, eNOS, and SDF-1 production. Abbreviations: SIRT1-PGC: sirtuin 1-gamma coactivator 1-α; AMPK: AMP-activated protein kinase; AGEs: advanced glycation end-products; ROS: reactive oxygen species; Nfr2: nuclear factor erythroid 2-related factor 2; NO: oxide nitric; TGF-β1: transforming growth factor-beta 1; ECM: extracellular matrix; VEGF: vascular endothelial growth factor; eNOS: endothelial nitric oxide synthase; SDF-1: stromal cell-derived factor-1α. (A color version of this figure is available in the online journal.)
Exercise training improves glucose homeostasis
Skeletal muscle is known to play an important role in glucose homeostasis by increasing insulin-mediated glucose uptake117 and activation of AMP-activated protein kinase (AMPK) during exercise.118 Theses mechanisms have been demonstrated in both healthy individuals and patients with T2DM.119
With regard to the insulin-dependent pathway, exercise training actives insulin signaling cascade elements, such as insulin receptor substrate 1 (IRS-1), phosphatidylinositol 3-kinase (PI3-K), phosphoinositide-dependent kinase (PDK), atypical protein kinase C (aPKC) and serine/threonine-protein kinases (Akt), inducing GLUT4 expression and translocation to the cell membrane.89 Holten et al.120 demonstrated that subjects with T2DM had a 40% increase of type 4 glucose transporter (GLUT4) density in the trained muscle when compared to untrained muscle. According to Park et al.,121 the exercise increases GLUT4 expression and translocation in T2DM by increasing the calcium flow during muscle contraction and levels of ADP-ribose/NAADP (cADPR) and d-myo-inositol 1,4,5-triphosphate/nicotinic acid adenine dinucleotide phosphate (NAADP), which results in increased contraction-induced glucose uptake.121
On the other hand, AMPK is a kinase that coordinates anabolic and catabolic pathways to balance the supply of nutrients with the demand for energy, both at the cellular level and in the body as a whole.122,123 When the muscle is stimulated by exercise, the ATP turnover is increased by more than 100 times, which leads to an increase in ATP consumption and a consequent increase in intracellular AMP levels due to the reaction of adenylate kinase.124 This increase leads to skeletal muscle hyperemia, capillary recruitment, as well as translocation of GLUT4 to the plasma membrane, thereby increasing the uptake of glucose by the muscle,122,125 as demonstrated in healthy rats126 and humans.127 In this sense, it was also demonstrated that exercise increased AMPK α2 activity in both the patients with T2DM and healthy individuals, and this activity was significantly increased by 2.7-fold over basal in T2DM patients.128 In another study, subjects with T2DM submitted a six-week strength-training program only in one leg (the other leg remained untrained) present increased protein expression for the α1, β2, and γ1 AMPK subunit isoform in the trained leg when compared to the leg untrained.119 Taken together, this evidence shows that the AMPK pathway is an important regulator of exercise-mediated glucose homeostasis in both healthy and diabetic individuals.
Exercise training attenuates oxidative stress and inflammation
Literature data have shown that improvement of the catabolic process and up-regulation of antioxidant enzyme activity may be possible mechanisms by which exercise reduces oxidative stress and inflammation, providing attenuation of renal damage in the DKD.8,19,90 Although few studies have shown the involvement of these mechanisms in humans, recently Dong et al.90 demonstrated that moderate chronic aerobic exercise plus caloric restriction induced cardiometabolic improvement, reduced the levels of malondialdehyde (lipid peroxidation marker), 8-OHdG (oxidative damage to DNA marker) and IL-6, and increased concomitantly the serum activity of the antioxidant enzyme superoxide dismutase (SOD) in patients with T2DM in stage 3 DKD.90 However, the set of data available in the literature that support this hypothesis is even greater in experimental studies. Thus, moderate-intensity exercise training reduced the renal lipid peroxidation8,17,19,86 and increased the glutathione peroxidase (GPx) activity in STZ-induced diabetic rats.8,86 This type of exercise was also able to reduce advanced glycation in obese diabetic rats95 and increase the SOD activity in type 2 diabetic model KK-Ay mice.129 Although the molecular pathway by which exercise attenuates oxidative stress are not fully understood, evidence suggests that exercise training down-regulates the purinoceptor 7 (P2X7), which is related to increased lipid peroxidation in STZ-induced diabetic rat.86 Other studies demonstrated that exercise up-regulated Sirtuin 1 (Sirt1), the main regulator of mitochondrial function, and increased the mitochondrial complex expression via induction of peroxisome proliferator-activated receptor gamma coactivator 1-α (PGC-1α) to improve renal enzymatic activity in diabetic mice.57,85
Exercise training also increases the nuclear factor erythroid 2-related factor 2 (Nrf2) expression, a transcription factor that up-regulates the antioxidant enzymes and anti-inflammatory cytokines expressions in renal diseases in both patients on dialysis106,107 and experimental animals.130,131 The modulation of Nrf2 mediated by exercise can be explained by increased energy demand during physical activity, leading to increase in oxygen consumption and consequent ROS production. The excess of ROS in turn induces a state of temporary oxidative stress that contributes to increased Nrf2 activation.132
Studies from our laboratory reported that moderate-intensity aerobic exercise, especially when started before induction of DM, reduced the NF-кB, ED-1 and CD43-positive cells (macrophage and lymphocyte markers, respectively) and attenuated the expression of TGF-β1, fibronectin, and collagen IV in STZ-induced diabetic female rats.7,8,19 Other studies have also shown that moderate-intensity aerobic exercise suppressed NF-κB activity via restoration of SIRT1 expression in kidney of diabetic db/db mice57 and reduced the renal expression of MCP-1.129 This is important because pro-inflammatory cytokine and chemotactic proteins genes transcription are induced by activation of NF-κB, which leads to further increases in ROS production, creating a cyclic positive feedback mechanism that accelerates the progression of DKD.133,134
Exercise training modulates the renin-angiotensin-aldosterone system
Some studies with experimental animals showed the effects of exercise training on classical RAAS components. In the sense, Somineni et al.135 demonstrated that 10 weeks of exercise training program decreased urinary angiotensin-converting enzyme 2 (ACE2) activity, which was positively correlated to albuminuria, blood glucose, plasma glucagon, and triglycerides and negatively correlated with plasma insulin levels in a model of diabetic rats, suggesting that ACE2 can be used as a biomarker for DKD.
Studies with other CKD experimental models, besides demonstrating downregulation of RAAS classical components, also showed upregulation of counter-regulatory components of this system. This is important because the effects opposing to the classical arm, such as the ACE2/Angiotensin (1–7)/Mas receptor axis, are present in anti-inflammatory, vasodilator, antiproliferative, cardioprotective, and renoprotective actions.136 In this sense, Agarwal et al.133 demonstrated that 16 weeks of aerobic exercise preserved renal structure and hemodynamics by reducing the ACE, angiotensin II receptor type 1 (AT1R) expressions and plasma AII, besides increasing the ECA2 and MasR expressions in rats with hypertension-induced CKD. Aerobic exercise also increased the fractional urinary sodium excretion (FENa), which was associated to reduce the AT1R, Janus Kinase 2 (JAK-2), and signal transducer and activator of transcription 3 (STAT-3) expressions, and increase the suppressor of cytokine signaling 3 (SOCS-3) and extracellular signal-regulated kinase (ERK1/2) expressions in the kidneys of hypertensive old rats. These effects contributed to the reduction of blood pressure levels found in these animals, thus contributing to the preservation of renal function.137
Recently, Magalhães et al.138 investigated the acute effects of two physical exercise protocols, high-intensity-intermittent training (HIIT) and moderate-intensity-continuous training (MICT), on plasma and urinary concentrations of the RAAS components. Thus, these authors demonstrated that the MICT protocol resulted in a decrease in the ACE plasma levels and increased the ACE2 urine levels, the HIIT protocol induced a significant increase in ACE2 plasma levels, while both protocols increased Angiotensin (1–7) urine levels in young healthy individuals. These results suggest an enzymatic modulation in both protocols favoring the balance towards the activation of the counter-regulatory axis of RAAS.
Exercise training improves endothelial function
Exercise training can slow the progression of DKD through improvements in endothelial function. Sallam et al.139 reported that moderate-intensity aerobic exercise significantly improved endothelium-dependent relaxation in diabetic mice (db/db). In addition, this type of exercise increased the angiogenesis, NO, and VEGF renal levels, and endothelial nitric oxide synthase (eNOS) and stromal cell-derived factor-1α (SDF-1) expressions. SDF-1 is a chemokine involved in kidney repair in experimental nephrotoxicity models.140,141
Furthermore, De Moraes et al. proposed that increased endothelial NO production induced by exercise is due to repetitive episodes of increased shear stress resulting from increased cardiac output and renal vasoconstriction. These authors demonstrated in exercised rabbits that increased renal blood flow immediately after a session of physical activity is associated with the increase of antioxidant enzymes, which inactivate ROS, thereby increasing NO bioavailability.142
Importantly, NO has been shown to inhibit TGF-β bioactivity and fibronectin synthesis in mesangial cell culture.143 Increased mesangial expansion, thickening of the glomerular basement membrane, collagen IV expression, and tubulointerstitial fibrosis have been demonstrated in inducible nitric oxide synthase (iNOS) knockout (KO) mice.144 Other researchers have also pointed to NO as a repressor of ECM expansion and attenuator of tissue fibrosis.144,145 Thus, it is reasonable to assume that increased NO bioavailability induced by exercise training19 may contribute, at least in part, to the reduction of TGF-β expression and ECM accumulation in DKD.7
Final considerations
In summary, exercise training is considered as an important strategy for achieving metabolic control, glycemic homeostasis, and prevention of DM complications. Therefore, it is particularly important to know the overall effects of different types of exercise in the context that DKD is present. Based on the most recent studies, the evidence suggests that the beneficial effects of exercise on the DKD are directly related to the type and intensity of exercise, as well as the types of DM. Thus, we suggest that the exercise training can contribute positively to improve the health and quality of life of patients with DM, preventing and attenuating the progression of DKD.
Authors’ contributions
All authors contributed to the writing, design and review of the manuscript.
DECLARATION OF CONFLICTING INTERESTS
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
FUNDING
The author(s) received no financial support for the research, authorship, and/or publication of this article.
ORCID iD
Telma de Jesus Soares https://orcid.org/0000-0002-5500-2930
References
- 1.International Diabetes Federation. Global Picture. IDF diabetes atlas, 9th ed Brussels, Belgium : International Diabetes Federation , 2019, p.34 [Google Scholar]
- 2.Buch A, Eldor R, Kis O, Keinan-Boker L, Dunsky A, Rubin A, Lopez A, Sofer Y, Osher E, Marcus Y, Stern N. The effect of circuit resistance training, empagliflozin or “vegeterranean diet” on physical and metabolic function in older subjects with type 2 diabetes: a study protocol for a randomized control trial (CEV-65 trial). BMC Geriatr 2019; 19:12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK; CARMELINA Investigators. Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial. JAMA 2019; 321:69–79 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Papadopoulou-Marketou N, Ps Marketos N, Adamidi S, Adamidis S, Kanaka-Gantenbein C. Diabetic nephropathy in type 1 diabetes. Minerva Med 2018; 109:218–28 [DOI] [PubMed] [Google Scholar]
- 5.Macisaac R, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis 2014; 63:S39–62 [DOI] [PubMed] [Google Scholar]
- 6.Kurdak H, Sandikci S, Ergen N, Dogan A, Kurdak SS. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis 2014; 63:39–62 [DOI] [PubMed] [Google Scholar]
- 7.Amaral L, Silva FA, Correia VB, Andrade CE, Dutra BA, Oliveira MV, Magalhães AC, Volpini RA, Seguro AC, Coimbra TM, Soares TJ. Beneficial effects of previous exercise training on renal changes in streptozotocin-induced diabetic female rats. Exp Biol Med 2016; 241:437–45 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Souza C, Oliveira BSS, Viana GN, Correia TML, Bragança AC, Canale D, Oliveira MV, Magalhães A, Volpini RA, Amaral LSB, Soares TJ. Preventive effect of exercise training on diabetic kidney disease in ovariectomized rats with type 1 diabetes. Exp Biol Med 2019; 244:758–69 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.A, Kumar P, Welsh GI, Saleem MA, Menon RK. Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus. Front Endocrinol 2014; 5:1–13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bermejo S, Pascual J, Soler MJ. The large spectrum of renal disease in diabetic patients. Clin Kidney J 2017; 10:255–6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Magee G, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 2009; 52:691–7 [DOI] [PubMed] [Google Scholar]
- 12.Ficociello L, Perkins BA, Roshan B, Weinberg JM, Aschengrau A, Warram JH, Krolewski AS. Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 2009; 32:889–93 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Akhtar M, Taha NM, Nauman A, Mujeeb IB, Dakhilalla A. Diabetic kidney disease: past and present. Adv Anat Pathol 2019; 27:87–97 [DOI] [PubMed] [Google Scholar]
- 14.Sharma K, McGowan TA. TGF-β in diabetic kidney disease: role of novel signaling pathways. Cytokine Growth Factor Rev 2000; 11:115–23 [DOI] [PubMed] [Google Scholar]
- 15.Schnackenberg C. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 2002; 282:335–42 [DOI] [PubMed] [Google Scholar]
- 16.Kopel J, Pena-Hernandez C, Nugent K. Evolving spectrum of diabetic nephropathy. World J Diab 2019; 10:269–79 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Rodrigues A, Bergamaschi CT, Araujo RC, MouroMG Rosa TS, Higa EM. Effects of training and nitric oxide on diabetic nephropathy progression in type I diabetic rats. Exp Biol Med 2011; 236:1180–7 [DOI] [PubMed] [Google Scholar]
- 18.Lazarevic G, Antic S, Vlahovic P, Djordjevic V, Zvezdanovic L, Stefanovic V. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients. Renal Fail 2007; 29:199–205 [DOI] [PubMed] [Google Scholar]
- 19.Amaral L, Souza CS, Volpini RA, Shimizu MHM, Bragança AC, Canale D, Seguro AC, Magalhães AC, Coimbra TM, Soares TJ. Previous exercise training reduces markers of renal oxidative stress and inflammation in streptozotocin-induced diabetic female rats. J Diab Res 2018; 2018:1–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Tang S, Lai KN. The pathogenic role of the renal proximal tubular cell in diabetic nephropathy. Nephrol Dial Transplant 2012; 27:3049–56 [DOI] [PubMed] [Google Scholar]
- 21.Trevisan R, Dodesini AR. The hyperfiltering kidney in diabetes. Nephron 2017; 136:277–80 [DOI] [PubMed] [Google Scholar]
- 22.Thomson S, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004; 286:F8–F15 [DOI] [PubMed] [Google Scholar]
- 23.Persson P, Hansell P, Palm F. Tubular reabsorption and diabetes-induced glomerular hyperfiltration. Acta Physiol 2010; 200:3–10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Heerspink HP, Fitchett DH, Husain M, Cherney DZ. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications. Circulation 2016; 134:752–72 [DOI] [PubMed] [Google Scholar]
- 25.Rahmoune H, Thompson PW, Ward JM, Smith CD, Hong G, Brown J. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes 2005; 54:3427–34 [DOI] [PubMed] [Google Scholar]
- 26.Zhang J, Wei J, Jiang S, Xu L, Wang L, Cheng F, Buggs J, Koepsell H, Vallon V, Liu R. Macula densa SGLT1-NOS1-Tubuloglomerular feedback pathway, a new mechanism for glomerular hyperfiltration during hyperglycemia. J Am Soc Nephrol 2019; 30:578–93 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Veelken R, Hilgers KF, Hartner A, Haas A, Böhmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 2000; 11:71–9 [DOI] [PubMed] [Google Scholar]
- 28.Trevisan R, Barnes DJ, Viberti G. Pathogenesis of diabetic nephropathy In: John Pickup J, Williams J. (eds) Text book of diabetes. 2nd ed Oxford: Blackwell Science Ltd, 1997, pp. 52.1–52.21 [Google Scholar]
- 29.Stieger NW, Schiffer M. The role of metabolic and haemodynamic factors in podocyte injury in diabetes. Diabetes Metab Res Rev 2011; 27:207–15 [DOI] [PubMed] [Google Scholar]
- 30.Rivarola E, Moyses-Neto M, Dantas M, Da-Silva CG, Volpini R, Coimbra TM. Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy. Braz J Med Biol Res 1999; 32:1525–8 [DOI] [PubMed] [Google Scholar]
- 31.Woo V, Ni LS, Hak D, Berard L, Zhu F, Khan S, Ma GM, Penner B, Shen GX. Effects of losartan on urinary secretion of extracellular matrix and their modulators in type 2 diabetes mellitus patients with microalbuminuria. Clin Invest Med 2006; 29:365–72 [PubMed] [Google Scholar]
- 32.Striker G, Eastman RD, Striker LJ. Diabetic nephropathy: molecular analysis of extracellular matrix and clinical studies update. Nephrol Dial Transplant 1996; 11:58–61 [DOI] [PubMed] [Google Scholar]
- 33.Dam C. 17β-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-β protein expression and signaling. Am J Physiol 2007; 293:F1678–F90 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Volpini R, da Silva CG, Costa RS, Coimbra TM. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats. Diab Metab Res Rev 2003; 19:43–51 [DOI] [PubMed] [Google Scholar]
- 35.Mason R, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 2003; 14:1358–73 [DOI] [PubMed] [Google Scholar]
- 36.Hu C, Sun L, Xiao L, Han Y, Fu X, Xiong X, Xu X, Liu Y, Yang S, Liu F, Kanwar YS. Insights into the mechanisms involved in the expression and regulation of extracellular matrix proteins in diabetic nephropathy. Curr Med Chem 2015; 22:2858–70 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Araki S, Haneda M, Koya D, Isshiki K, Kume S, Sugimoto T, Kawai H, Nishio Y, Kashiwagi A, Uzu T, Maegawa H. Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care 2010; 33:1805–10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Okonogi H, Nishimura M, Utsunomiya Y, Hamaguchi K, Tsuchida H, Miura Y, Suzuki S, Kawamura T, Hosoya T, Yamada K. Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol 2001; 55:357–64 [PubMed] [Google Scholar]
- 39.Singh R, Howarth FC, Adeghate E, Bidasee K, Singh J, Waqar T. Type 1 diabetes mellitus induces structural changes and molecular remodelling in the rat kidney. Mol Cell Biochem 2018; 449:9–25 [DOI] [PubMed] [Google Scholar]
- 40.Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, van Ypersele de Strihou C, Kurokawa K. Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int 1998; 53:416–22 [DOI] [PubMed] [Google Scholar]
- 41.Throckmorton D, Brogden AP, Min B, Rasmussen H, Kashgarian M. PDGF and TGF-Beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 1995; 48:111–7 [DOI] [PubMed] [Google Scholar]
- 42.Liao Y, Lee YH, Chuang LY, Guh JY, Shi MD, Huang JS. Advanced glycation end Products-Mediated hypertrophy is negatively regulated by tetrahydrobiopterin in renal tubular cells. Mol Cell Endocrinol 2012; 355:71–7 [DOI] [PubMed] [Google Scholar]
- 43.Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products sparking the development of diabetic vascular injury. Circulation 2006; 114:597–605 [DOI] [PubMed] [Google Scholar]
- 44.Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 6865:813–20 [DOI] [PubMed] [Google Scholar]
- 45.Brownlee M. The pathobiology of diabetic complications a unifying mechanism. Diabetes 2005; 54:1615–25 [DOI] [PubMed] [Google Scholar]
- 46.Henry D, Busik JV, Brosius FC, 3rd, Heilig CW. Glucose transporters control gene expression of aldose reductase, PKCα, and GLUT1 in mesangial cells in vitro. Am J Physiol 1999; 277:F97–F104 [DOI] [PubMed] [Google Scholar]
- 47.Way K, Katai N, King GL. Protein kinase C and the development of diabetic vascular complications. Diabet Med 2001; 18:945–59 [DOI] [PubMed] [Google Scholar]
- 48.Yung S, Chau MK, Zhang Q, Zhang CZ, Chan TM. Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy. PLoS One 2013; 8:e54501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase cbeta-null mice. Diabetes 2006; 55:3112–20 [DOI] [PubMed] [Google Scholar]
- 50.Navarro-González J, Mora-Fernández C, Fuentes MM, García-Pérez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 2011; 7:327–40 [DOI] [PubMed] [Google Scholar]
- 51.Shikata KM. Microinflammation in the pathogenesis of diabetic nephropathy. J Diab Investig 2013; 4:142–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci 2013; 124:139–52 [DOI] [PubMed] [Google Scholar]
- 53.Patel S, Santani D. Role of NF-κB in the pathogenesis of diabetes and its associated complications. Pharmacol Rep 2009; 61:595–603 [DOI] [PubMed] [Google Scholar]
- 54.Jha J, Banal C, Chow BSC, Cooper ME, Jandeleit-Dahm K. Diabetes and kidney disease: role of oxidative stress. Antioxid Redox Signal 2016; 25:657–84 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Suryavanshi S, Kulkarni YA. NF-kb: a potential target in the management of vascular complications of diabetes. Front Pharmacol 2017; 8:1–12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Pérez-Morales R, del Pino MD, Valdivielso JM, Ortiz A, Mora-Fernández C, Navarro-González JF. Inflammation in diabetic kidney disease. Nephron 2019; 143:12–6 [DOI] [PubMed] [Google Scholar]
- 57.Liu H, Kao HH, Wu CH. Exercise training upregulates SIRT1 to attenuate inflammation and metabolic dysfunction in kidney and liver of diabetic db/db mice. Nutr Metab 2019; 16:22–32 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Tarabra E, Giunti S, Barutta F, Salvidio G, Burt D, Deferrari G, Gambino R, Vergola D, Pinach S, Perin PC, Camussi G, Gruden G. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes 2009; 54:2109–18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Matoba K, Takeda Y, Nagai Y, Kawanami D, Utsunomiya K, Nishimura R. Unraveling the role of inflammation in the pathogenesis of diabetic kidney disease. Int J Mol Sci 2019; 20:1–15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Landis R, Quimby KR, Greenidge AR. M1/M2 macrophages in diabetic nephropathy: Nrf2/HO-1 as therapeutic targets. Curr Pharm Des 2018; 24:2241–9 [DOI] [PubMed] [Google Scholar]
- 61.Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, Wada J, Shikata Y, Makino H. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 2003; 52:2586–93 [DOI] [PubMed] [Google Scholar]
- 62.Lim A, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inf lamm 2012; 2012:1–12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.A/L B Vasanth Rao V, Tan SH, Candasamy M, Bhattamisra SK. Diabetic nephropathy: an update on pathogenesis and drug development. Diabetes Metab Syndr 2019; 13:754–62 [DOI] [PubMed] [Google Scholar]
- 64.Navarro-González J, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19:433–42 [DOI] [PubMed] [Google Scholar]
- 65.Nava M, Quiroz Y, Vaziri N, Rodríguez-Iturbe B. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol 2003; 284:F447–F54 [DOI] [PubMed] [Google Scholar]
- 66.Rodríguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 2004; 286:F606–F16 [DOI] [PubMed] [Google Scholar]
- 67.Garber C, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011; 43:1334–59 [DOI] [PubMed] [Google Scholar]
- 68.Colberg S, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, Horton ES, Castorino K, Tate DF. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016; 39:2065–79 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Snowling N, Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care 2006; 29:2518–27 [DOI] [PubMed] [Google Scholar]
- 70.Chimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R, Narendran P. What are the health benefits of physical activity in type 1 diabetes mellitus? a literature review. Diabetologia 2012; 55:542–51 [DOI] [PubMed] [Google Scholar]
- 71.Barlovic D, Tikkanen-Dolenc H, Groop PH. Physical activity in the prevention of development and progression of kidney disease in type 1 diabetes. Curr Diab 2019; 19:1–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Miyamoto N, Senjyu H, Tanaka T, Asai M, Yanagita Y, Yano Y. Pulmonary rehabilitation improves exercise capacity and dyspnea in air pollution-related respiratory disease. Tohoku J Exp Med 2014; 232:1–8 [DOI] [PubMed] [Google Scholar]
- 73.Mendelson M, Lyons OD, Yadollahi A, Inami T, Oh P, Bradley TD. Effects of exercise training on sleep apnea in patients with coronary artery disease: a randomized trial. Eur Respir J 2016; 48:142–5 [DOI] [PubMed] [Google Scholar]
- 74.Villareal D, Aguirre L, Gurney AB, Waters DL, Sinacore DR, Colombo E. Aerobic or resistance exercise, or both, in dieting obese older adults. N Engl J Med 2017; 376:1943–55 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Ferraz D, Trippo KV, Duarte GP, Neto MG, Bernardes Santos KO, Filho JO. The effects of functional training, bicycle exercise, and exergaming on walking capacity of elderly patients with Parkinson disease: a pilot randomized controlled single-blinded trial. Arch Phys Med Rehabil 2018; 99:826–33 [DOI] [PubMed] [Google Scholar]
- 76.Thompson S, Wiebe N, Gyenes G, Davies R, Radhakrishnan J, Graham M. Physical activity in renal disease (PAIRED) and the effect on hypertension: study protocol for a randomized controlled trial. Trials 2019; 20:1–10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Luan X, Tian X, Zhang H, Huang R, Li N, Chen P, Wang R. Exercise as a prescription for patients with various diseases. J Sport Health Sci 2019; 8:422–41 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Barker K, Eickmeyer S. Therapeutic exercise. Med Clin North Am 2020; 104:189–98 [DOI] [PubMed] [Google Scholar]
- 79.Johannsen N, Swift DL, Lavie CJ, Earnest CP, Blair SN, Church TS. Combined aerobic and resistance training effects on glucose homeostasis, fitness, and other major health indices: a review of current guidelines. Sports Med 2016; 46:1809–18 [DOI] [PubMed] [Google Scholar]
- 80.Nikolovski Z, Barbaresi S, Cable T, Peric R. Evaluating the influence of differences in methodological approach on metabolic thresholds and fat oxidation points relationship. Eur J Sport Sci 2020; 31:1–8 [DOI] [PubMed] [Google Scholar]
- 81.Yaribeygi H, Butler AE, Sahebkar A. Aerobic exercise can modulate the underlying mechanisms involved in the development of diabetic complications. J Cell Physiol 2019; 234:12508–15 [DOI] [PubMed] [Google Scholar]
- 82.Pechter U, Ots M, Mesikepp S, Zilmer K, Kullissaar T, Vihalemm T, Zilmer M, Maaroos J. Beneficial effects of water-based exercise in patients with chronic kidney disease. Int J Rehabil Res 2003; 26:153–6 [DOI] [PubMed] [Google Scholar]
- 83.Sigal R, Kenny GP, Wasserman DH, Castaneda-Sceppa C. Physical activity/exercise and type 2 diabetes. Diab Care 2004; 27:2518–39 [DOI] [PubMed] [Google Scholar]
- 84.Tikkanen-Dolenc H, Wadén J, Forsblom C, Harjutsalo V, Thorn LM, Saraheimo M, Elonen N, Tikkanen HO, Groop PH. Physical activity reduces risk of premature mortality in patients with type 1 diabetes with and without kidney disease. Diab Care 2017; 40:1727–32 [DOI] [PubMed] [Google Scholar]
- 85.Tang L, Wang B, Wu ZK. Aerobic exercise training alleviates renal injury by interfering with mitochondrial function in type-1 diabetic mice. Med Sci Monit 2018; 24:9081–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Rodrigues A, Bergamaschi CT, Fernandes MJ, Paredes-Gamero EJ, Buri MV, Ferreira AT, Araujo SR, Punaro GR, Maciel FR, Nogueira GB, Higa EM. P2X(7) receptor in the kidneys of diabetic rats submitted to aerobic training or to N-acetylcysteine supplementation [corrected. PLoS One 2014; 9:e97452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Turksoy K, Paulino TM, Zaharieva DP, Yavelberg L, Jamnik V, Riddell MC, Cinar A. Classification of physical activity: information to artificial pancreas control systems in real time. J Diab Sci Technol 2015; 9:1200–7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Nylen E, Gandhi SM, Kheirbek R, Kokkinos P. Enhanced fitness and renal function in type 2 diabetes. Diabet Med 2015; 32:1342–5 [DOI] [PubMed] [Google Scholar]
- 89.Rohling M, Helder C, Stemper T, Mussig K. Influence of acute and chronic exercise on glucose uptake. Journal of Diabetes Research 2016;2016:1--33 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Dong L, Li J, Lian Y, Tang ZX, Zen Z, Yu P, Li Y. Long-Term intensive lifestyle intervention promotes improvement of stage III diabetic nephropathy. Med Sci Monit 2019; 25:3061–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Wallberg-Henriksson H, Gunnarsson R, Rossner S, Wahren J. Long-term physical training in female type 1 (insulin-dependent) diabetic patients: absence of significant effect on glycaemic control and lipoprotein levels. Diabetologia 1986; 29:53–7 [DOI] [PubMed] [Google Scholar]
- 92.Ramalho A, Lima ML, Nunes F, Cambui Z, Barbosa C, Andrade A, Viana A, Martins M, Abrantes V, Aragão C, Temístocles M. The effect of resistance versus aerobic training on metabolic control in patients with type-1 diabetes mellitus. Diab Res Clin Pract 2006; 72:271–6 [DOI] [PubMed] [Google Scholar]
- 93.Teixeira-Lemos EN, Teixeira F, Reis F. Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol 2011; 10:10–2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Silveira M, Amaral LSB, Souza SI, Ferraz HR, Dias JA, Rocha EC, Silva FA, Magalhães ACM, Soares TJ. Effect of moderate exercise on renal changes and oxidative stress in ovariectomized rats with type 1 diabetes mellitus. Braz J Biol Sci 2019; 6:331–45 [Google Scholar]
- 95.Boor P, Celec P, Behuliak M, Grancic P, Kebis A, Kukan M, Pronayová N, Liptaj T, Ostendorf T, Sebeková K. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese zucker rats. Metab Clin Exp 2009; 58:1669–77 [DOI] [PubMed] [Google Scholar]
- 96.Poortmans J, Geudvert C, Schorokoff K, De Plaen P. Postexercise proteinuria in childhood and adolescence. Int J Sports Med 1996; 17:448–51 [DOI] [PubMed] [Google Scholar]
- 97.Brazeau A, Rabasa-Lhoret R, Strychar I, Mircescu H. Barriers to physical activity among patients with type 1 diabetes. Diab Care 2008; 31:2108–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Marliss E, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes 2002; 1:S271–83 [DOI] [PubMed] [Google Scholar]
- 99.Fahey A, Paramalingam N, Davey RJ, Davis EA, Jones TW, Fournier PA. The effect of a short sprint on postexercise whole-body glucose production and utilization rates in individuals with type 1 diabetes mellitus. J Clin Endocrinol Metab 2012; 97:4193–200 [DOI] [PubMed] [Google Scholar]
- 100.Bongers C, Alsady M, Nijenhuis T, Tulp ADM, Eijsvogels TMH, Deen PMT, Hopman M. Impact of acute versus prolonged exercise and dehydration on kidney function and injury. Physiol Rep 2018; 6:1–11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Wolyniec W, Kasprowicz K, Rita-Tkachenko P, Renke M, Ratkowski W. Biochemical markers of renal hypoperfusion, hemoconcentration, and proteinuria after extreme physical exercise. Med 2019; 55:154–65 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Gunduz F, Kuru O, Senturk UK. The effect of reactive oxidant generation in acute exercise-induced proteinuria in trained and untrained rats. Eur J Appl Physiol 2003; 90:526–32 [DOI] [PubMed] [Google Scholar]
- 103.Cosenzi A, Carraro M, Sacerdote A, Franca G, Piemontesi A, Bocin E, Faccini L, Bellini G. Involvement of the renin angiotensin system in the pathogenesis of postexercise proteinuria. Scand J Urol Nephrol 1993; 27:301–4 [DOI] [PubMed] [Google Scholar]
- 104.Poortmans J, Haggenmacher C, Vanderstraeten J. Postexercise proteinuria in humans and its adrenergic component. J Sports Med Phys Fitness 2001; 41:95–100 [PubMed] [Google Scholar]
- 105.Martínez R, Kapravelou G, López-Chaves C, Cáceres E, Coll-Risco I, Sánchez-González C, Llopis J, Arrebola F, Galisteo M, Aranda P, López-Jurado M, Porres JM. Aerobic interval exercise improves renal functionality and affects mineral metabolism in obese zucker rats. Am J Physiol Renal Physiol 2019; 316:F90–F100 [DOI] [PubMed] [Google Scholar]
- 106.Abreu C, Cardozo L, Stockler-Pinto MB, Esgalhado M, Barboza JE, Frauches R, Mafra D. Does resistance exercise performed during dialysis modulate Nrf2 and NF-κB in patients with chronic kidney disease? Life Sci 2017; 188:192–7 [DOI] [PubMed] [Google Scholar]
- 107.Moraes C, Marinho SM, da Nobrega AC, de Oliveira Bessa B, Jacobson LV, Stockler-Pinto MB, da Silva WS, Mafra D. Resistance exercise: a strategy to attenuate inflammation and protein-energy wasting in hemodialysis patients? Int Urol Nephrol 2014; 46:1655–62 [DOI] [PubMed] [Google Scholar]
- 108.Eriksson J, Taimela S, Eriksson K, Parviainen S, Peltonen J, Kujala U. Resistance training in the treatment of non-insulin-dependent diabetes mellitus. Int J Sports Med 1997; 18:242–6 [DOI] [PubMed] [Google Scholar]
- 109.Honkola FT, Eriksson J. Resistance training improves the metabolic profile in individuals with type 2 diabetes. Acta Diabetol 1997; 34:245–8 [DOI] [PubMed] [Google Scholar]
- 110.Fenicchia L, Kanaley JA, Azevedo JL, Jr, Miller CS, Weinstock RS, Carhart RL, Ploutz-Snyder LL. Influence of resistance exercise training on glucose control in women with type 2 diabetes. Metabolism 2004; 53:284–9 [DOI] [PubMed] [Google Scholar]
- 111.Yardley J, Kenny GP, Perkins BA, Riddell MC, Malcolm J, Boulay P, Khandwala F, Sigal RJ. Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes. Diab Care 2012; 35:669–75 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.McDonald M, Dotzert MS, Jiang M, Murray MR, Noble EG, James Melling C. Exercise training induced cardioprotection with moderate hyperglycemia versus sedentary intensive glycemic control in type 1 diabetic rats. J Diab Res 2018; 2018:1–10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Eves N, Plotnikoff RC. Resistance training and type 2 diabetes. Diab Care 2006; 29: 1933–41 [DOI] [PubMed] [Google Scholar]
- 114.Cuff D, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diab Care 2003; 26:2977–82 [DOI] [PubMed] [Google Scholar]
- 115.Sigal R, Kenny GP, Boulé NG, Wells GA, Prud’homme D, Fortier M, Reid RD, Tulloch H, Coyle D, Phillips P, Jennings A, Jaffey J. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 2007; 147:357–69 [DOI] [PubMed] [Google Scholar]
- 116.Yamamoto-Kabasawa K, Hosojima M, Yata Y, Saito M, Tanaka N, Tanaka J, Tanabe N, Narita I, Arakawa M, Saito A. Benefits of a 12-week lifestyle modification program including diet and combined aerobic and resistance exercise on albuminuria in diabetic and non-diabetic japanese populations. Clin Exp Nephrol 2015; 19:1079–89 [DOI] [PubMed] [Google Scholar]
- 117.Christopher M, Rantzau C, McConell G, Kemp BE, Alford FP. Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs. J Appl Physiol 2005; 98:930–9 [DOI] [PubMed] [Google Scholar]
- 118.Ho-Jin K. Regulation of exercise-stimulated glucose uptake in skeletal muscle. Ann Pediatr Endocrinol Metab 2016; 21:61–5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Wojtaszewski J, Birk JB, Frøsig C, Holten M, Pilegaard H, Dela F. 5′AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes. J Physiol 2005; 2:563–73 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Holten M, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004; 53:294–305 [DOI] [PubMed] [Google Scholar]
- 121.Park D, Park KH, Kim BJ, Yoon CS, Kim UH. Exercise ameliorates insulin resistance via Ca2+ signals distinct from those of insulin for GLUT4 translocation in skeletal muscles. Diabetes 2015; 64:1224–34 [DOI] [PubMed] [Google Scholar]
- 122.Mounier R, Théret M, Lantier L, Foretz M, Viollet B. Expanding roles for AMPK in skeletal muscle plasticity. Trends Endocrinol Metab 2015; 26:275–86 [DOI] [PubMed] [Google Scholar]
- 123.Janzen NR, Wj, Hoffman NJ. Interactive roles for AMPK and glycogen from cellular energy sensing to exercise metabolism. Int J Mol Sci 2018; 19:1–18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Viollet B. The energy sensor AMPK: adaptations to exercise, nutritional and hormonal signals. In: Spiegelman B (ed) Hormones, metabolism and the benefits of exercise. Cham: Springer, 2017, pp.13–24 [PubMed]
- 125.Richter E, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 2013; 93:993–1017 [DOI] [PubMed] [Google Scholar]
- 126.Winder W, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 1996; 270:E299–304 [DOI] [PubMed] [Google Scholar]
- 127.Wojtaszewski J, Nielsen P, Hansen BF, Richter EA, Kiens B. Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol 2000; 528:221–6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Musi NFN, Hirshman MF, Ekberg I, Fröberg S, Ljungqvist O, Thorell A, Goodyear LJ. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 2001; 50:921–7 [DOI] [PubMed] [Google Scholar]
- 129.Ishikawa Y, Gohda T, Tanimoto M, Omote K, Furukawa M, Yamaguchi S, Murakoshi M, Hagiwara S, Horikoshi S, Funabiki K, Tomino Y. Effect of exercise on kidney function, oxidative stress, and inflammation in type 2 diabetic KK-AyMice. Exp Diab Res 2012; 2012:1–10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Asghar M, George L, Lokhandwala MF. Exercise decreases oxidative stress and inflammation and restores renal dopamine D1 receptor function in old rats. Am J Physiol Renal Physiol 2007; 293:F914–F19 [DOI] [PubMed] [Google Scholar]
- 131.Sahin K, Tuzcu M, Sahin N, Ali S, Kucuk O. Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food Chem Toxicol 2010; 48:2670–4 [DOI] [PubMed] [Google Scholar]
- 132.J G-CMS-PACHFBVa. Redox modulation of mitochondriogenesis in exercise. Does antioxidant supplementation blunt the benefits of exercise training? Free Radical Bio Med 2015; 86:37–46 [DOI] [PubMed] [Google Scholar]
- 133.Agarwal D, Elks CM, Reed SD, Mariappan N, Majid DS, Francis J. Chronic exercise preserves renal structure and hemodynamics in spontaneously hypertensive rats. Antioxid Redox Signal 2012; 16:139–52 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Li H, Huo CJ, Su Q, Li X, Bai J, Zhu GQ, Kang YM. Exercise training attenuates proinflammatory cytokines, oxidative stress and modulates neurotransmitters in the rostral ventrolateral medulla of Salt-Induced hypertensive rats. Cell Physiol Biochem 2018; 48:1369–81 [DOI] [PubMed] [Google Scholar]
- 135.Somineni H, Boivin GP, Elased KM. Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice. J Endocrinol 2014; 221:235–51 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Santos R, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M. The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7). Physiol Rev 2018; 98:505–53 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Ciampone S, Borges R, de Lima IP, Mesquita FF, Cambiucci EC, Gontijo JA. Long-term exercise attenuates blood pressure responsiveness and modulates kidney angiotensin II signalling and urinary sodium excretion in SHR. J Renin Angiotensin Aldosterone Syst 2011; 12:394–403 [DOI] [PubMed] [Google Scholar]
- 138.Magalhães D, Nunes-Silva A, Rocha GC, Vaz LN, de Faria MHS, Vieira ELM, Rocha NP, Simões E Silva AC. Two protocols of aerobic exercise modulate the counter-regulatory axis of the renin-angiotensin system. Heliyon 2020; 6:e0320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Sallam N, Khazaei M, Laher I. Effect of moderate-intensity exercise on plasma C-reactive protein and aortic endothelial function in type 2 diabetic mice. Mediat Inf lamm 2010; 2010:149678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Faleiros C, Francescato HD, Papoti M, Chaves L, Silva CG, Costa RS, Coimbra TM. Effects of previous physical training on adriamycin nephropathy and its relationship with endothelial lesions and angiogenesis in the renal cortex. Life Sci 2017; 15:43–51 [DOI] [PubMed] [Google Scholar]
- 141.Francescato H, Almeida LF, Reis NG, Faleiros CM, Papoti M, Costa RS, Coimbra TM. Previous exercise effects in cisplatin-induced renal lesions in rats. Kidney Blood Press Res 2018; 2:582–93 [DOI] [PubMed] [Google Scholar]
- 142.De Moraes R, Gioseffi G, Nóbrega AC, Tibiriçá E. Effects of exercise training on the vascular reactivity of the whole kidney circulation in rabbits. J Appl Physiol 2004; 97:683–8 [DOI] [PubMed] [Google Scholar]
- 143.Studer R, De Rubertis FR, Craven PA. Nitric oxide suppresses increases in mesangial cell protein kinase C, transforming growth factor beta, and fibronectin synthesis induced by thromboxane. J Am Soc Nephrol 1996; 7:999–1005 [DOI] [PubMed] [Google Scholar]
- 144.Trachtman H, Futterweit S, Pine E, Mann J, Valderrama E. Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol 2002; 17:20–9 [DOI] [PubMed] [Google Scholar]
- 145.Rupprecht H, Akagi Y, Keil A, Hofer G. Nitric oxide inhibits growth of glomerular mesangial cells: role of the transcription factor EGR-1. Kidney Int 2000; 57:70–82 [DOI] [PubMed] [Google Scholar]


